Acute effects of hydrocortisone on the metabolic response to a glucose load: Increase in the first-phase insulin secretion

European Journal of Endocrinology

Volumn 163, Issue 2, 2010, Pages 225-231

  Vila, Greisa ^a   Krebs, Michael ^a   Riedl, Michaela ^a   Baumgartner Parzer, Sabina M ^a   Clodi, Martin ^a   Maier, Christina ^a   Pacini, Giovanni ^b   Luger, Anton ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GHRELIN; GLUCOSE; HYDROCORTISONE; HYDROCORTISONE SODIUM SUCCINATE; INSULIN; PEPTIDE YY; PLACEBO;

ADULT; ARTICLE; CELL FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; INSULIN RELEASE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; NORMAL HUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER CURVE; BLOOD GLUCOSE; C-PEPTIDE; CROSS-OVER STUDIES; GHRELIN; GLUCOSE; HUMANS; HYDROCORTISONE; INSULIN; MALE; PEPTIDE YY; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 77955361648     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0282     Document Type: Article

References (28)

1. Sapolsky RM, Romero LM & Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrine Reviews 2000 21 55-89.
2. Schäcke H, Döcke W-D & Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacology and Therapeutics 2002 96 23-43. (Pubitemid 35346616)
3. Andrews RC & Walker BR. Glucocorticoids and insulin resistance: old hormones, new targets. Clinical Science 1999 96 513-523.
4. Bamberger CM, Schulte HM & Chrousos GP. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocrine Reviews 1996 17 245-261.
5. Losel R & Wehling M. Nongenomic actions of steroid hormones. Nature Reviews. Molecular Cell Biology 2003 4 46-56.
6. Haller J, Mikics E & Makara GB. The effects of nongenomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings. Frontiers in Neuroendocrinology 2008 29 273-291.
7. Maier C, Rünzler D, Schindelar J, Grabner G, Waldhäusl W, Köhler G & Luger A. G-protein-coupled glucocorticoid receptors on the pituitary cell membrane. Journal of Cell Science 2005 118 3353-3361.
8. Watson CS & Gametchu B. Proteins of multiple classes may participate in nongenomic steroid actions. Experimental Biology and Medicine 2003 228 1272-1281.
9. de Kloet ER, Karst H & Joëls M. Corticosteroid hormones in the central stress response: quick-and-slow. Frontiers in Neuroendocrinology 2008 29 268-272.
10. Longano CA & Fletcher HP. Insulin release after acute hydrocortisone treatment in mice. Metabolism 1983 32 603-608. (Pubitemid 13099165)
11. Sutter-Dub MT. Rapid nongenomic and genomic responses to progestogens, estrogens, and GCs in the endocrine pancreatic B cell, the adipocyte and other cell types. Steroids 2002 67 77-93.
12. Löwenberg M, Tuynman J, Scheffer M, Verhaar A, Vermeulen L, van Deventer S, Hommes D & Peppelenbosch M. Kinome analysis reveals nongenomic glucocorticoid receptor-dependent inhibition of insulin signaling. Endocrinology 2006 147 3555-3562.
13. Plat L, Byrne MM, Sturis J, Polonsky KS, Mockel J, Féry F & Van Cauter E. Effects of morning cortisol elevation on insulin secretion and glucose regulation in humans. American Journal of Physiology 1996 270 E36-E42.
14. Schneiter P & Tappy L. Kinetics of dexamethasone-induced alterations of glucose metabolism in healthy humans. American Journal of Physiology 1998 275 E806-E813. (Pubitemid 28536320)
15. Bergman RN. Lilly Lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 1989 38 1512-1527.
16. Ahrén B & Pacini G. Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. European Journal of Endocrinology 2004 150 97-104.
17. Kahn SE, Prigeon RL, McCulloch DSK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC & Palmer JP. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993 42 1663-1672.
18. Pacini G, Tonolo G, Sambataro M, Maioli M, Ciccarese M, Brocco E, Avogaro A & Nosadini R. Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified FSIGT. American Journal of Physiology. Endocrinology and Metabolism 1998 274 E592-E599.
19. Stadler M, Anderwald C, Karer T, Tura A, Kästenbauer T, Auinger M, Bieglmayer C, Wagner O, Kronenberg F, Nowotny P, Pacini G & Prager R. Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation. A sign of impaired beta cell function? Diabetes Care 2006 29 1031-1038.
20. Pacini G & Bergman RN. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsitivity from the frequently sampled intravenous glucose tolerance test. Computer Methods and Programs in Biomedicine 1986 23 113-122. (Pubitemid 16027716)
21. Du J, Wang Y, Hunter R, Wei Y, Blumenthal R, Falke C, Khairova R, Zhou R, Yuan P, Machado-Vieira R, McEwen BS & Manji HK. Dynamic regulation of mitochondrial function by glucocorticoids. PNAS 2009 106 3543-3548.
22. Weber-Carstens S, Deja M, Bercker S, Dimroth A, Ahlers O, Kaisers U & Keh D. Impact of a bolus application of low-dose hydrocortisone on glycemic control in septic shock patients. Intensive Care Medicine 2007 33 730-733.
23. Lindgren O, Mari A, Deacon CF, Carr RD, Winzell MS, Vikman J & Ahrén B. Differential islet and incretin hormone responses in morning vs. afternoon after standardized meal in healthy men. Journal of Clinical Endocrinology and Metabolism 2009 94 2887-2892.
24. Marty N, Dallaporta M & Thorens B. Brain glucose sensing, counterregulation, and energy homeostasis. Physiology 2007 22 241-251.
25. Di S, Malcher-Lopes R, Halmos KC & Tasker JG. Nongenomic glucocorticoid inhibition via endocanabinoid release in the hypothalamus: a fast feed-back mechanism. Journal of Neuroscience 2003 23 4850-4857.
26. Dallman MF, la Fleur SE, Pecoraro NC, Gomez F, Houshyar H & Akana SF. Minireview: glucocorticoids - food intake, abdominal obesity, and wealthy nations in 2004. Endocrinology 2004 145 2633-2638.
27. Otto B, Tschöp M, Heldwein W, Pfeiffer AF & Diederich S. Endogenous and exogenous glucocorticoids decrease plasma ghrelin in humans. European Journal of Endocrinology 2004 151 113-117.
28. Batterham RL, Ffytche DH, Rosenthal JM, Zelaya FO, Barker GJ, Withers DJ & Williams SCR. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 2007 450 106-109.